MELE Melexis NV

Melexis Q3 2021 résultats – Chiffre d'affaires de 162.8 millions d'euros au troisième trimestre

Melexis Q3 2021 résultats – Chiffre d'affaires de 162.8 millions d'euros au troisième trimestre

Information réglementée

Déclaration intermédiaire par le Conseil d'administration

Ypres, Belgique - le 27 octobre 2021, 07.00 H. CET



Veuillez trouver ici le lien vers notre dernier communiqué de presse:

Pièce jointe



EN
27/10/2021

Underlying

MELEMelexis NV

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Melexis NV

Jerôme Bodin ... (+2)
  • Jerôme Bodin
  • Stephane Houri
INFINEON INFINEON TECHNO...
EDEN EDENRED SA ... (+19)

ODDO : Feedback from 10th ODDO BHF TMT Forum: Day 1

We are hosting our 10th ODDO BHF TMT Forum on 5 and 6 March 2026. In total, 35 companies will be presenting over the two days. In the following note, we provide some initial feedback from companies on day 1.

INFINEON INFINEON TECHNOLOGIES AG
EDEN EDENRED SA
SESGL SES SA FDR (CLASS A)
SOI SOITEC SA
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
MELE MELEXIS NV
TIT TELECOM ITALIA S.P.A.
FNTN FREENET AG
IDR INDRA SISTEMAS S.A. CLASS A
REY REPLY S.P.A.
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
WAVE WAVESTONE SA
AG1 AUTO1 GROUP
NA9 NAGARRO
DSY DASSAULT SYSTEMES SA
OVH OVH GROUPE
ARM ARM HOLDINGS PLC
EXENS EXOSENS
ALHG LOUIS HACHETTE GROUP
28m 28m 1 EN
Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg
MELE MELEXIS NV

Melexis/Slow start to the year/HOLD

Melexis delivered a disappointing 4Q25 update. After a guided slow start in 1Q26 we do not expect that FY26 to show meaningful growth vs FY25. Our long-term projections reflect the view that growth in Melexis' automotive semiconductor segment will be structurally lower going forward. We keep our HOLD and revise our target price downward to €50 per share (from €55).

03/05/26 March 5, 2026 1 EN
 PRESS RELEASE
Free
MELE MELEXIS NV

Melexis: update on the share buy-back program

Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 2 March 2026, 17.45 hrs CET Melexis reports the purchase of 20,500 Melexis shares on Euronext Brussels in the period from 23 February 2026 to 27 February 2026, related to the share buy-back program announced on 10 December 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)23/2/20264,50056.7956.3057.30255,56924/2/20263,50058.7156.6559.95205,47925/5/20264,00057.2556.9558.15229,01126/2/20264,00057.3856.5058.25229,52127/2/20264,50056.6756.0057...

March 2, 2026 1 EN
 PRESS RELEASE
Free
MELE MELEXIS NV

Melexis: update over het aandeleninkoopprogramma

Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 2 maart 2026, 17.45 uur CET Melexis meldt de aankoop van 20.500 Melexis-aandelen op Euronext Brussel in de periode van 23 februari 2026 tot 27 februari 2026, in het kader van het inkoopprogramma aangekondigd op 10 december 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)23/2/20264.50056,7956,3057,30255.56924/2/20263.50058,7156,6559,95205.47925/5/20264.00057,2556,9558,15229.01126/2/20264.00057,3856,5058,25229.52127/2/...

March 2, 2026 1 EN
 PRESS RELEASE
Free
MELE MELEXIS NV

Melexis: update on the share buy-back program

Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 23 February 2026, 17.45 hrs CET Melexis reports the purchase of 21,500 Melexis shares on Euronext Brussels in the period from 16 February 2026 to 20 February 2026, related to the share buy-back program announced on 10 December 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)16/2/20264,50056.1355.8056.55252,56717/2/20264,50056.0254.9056.55252,10118/2/20264,00058.4257.0559.45233,68119/2/20264,50057.8957.5058.65260,49520/2/20264,00057.4056....

February 23, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch